Clinical Trial Update: Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating allogeneic mesenchymal stem cell infusion therapy for endothelial dysfunction in adults with type 2 diabetes; study completed with po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Allogeneic mesenchymal stem cell infusion therapy

Snippet

Sponsor: Joshua M Hare | Conditions: Diabetes Mellitus, Type 2 | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-05-11